ID   NAMO-2
AC   CVCL_R913
DR   Wikidata; Q54907471
RX   PubMed=17118759;
CC   Population: Japanese.
CC   Doubling time: 30 hours (PubMed=17118759).
CC   Sequence variation: Mutation; HGNC; HGNC:3765; FLT3; Unexplicit; Internal tandem duplication (FLT3-ITD); ClinVar=VCV000016270; Zygosity=Unspecified (PubMed=17118759).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C7463; Acute myelomonocytic leukemia
DI   ORDO; Orphanet_517; Acute myelomonocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 12
//
RX   PubMed=17118759; DOI=10.1532/IJH97.06056;
RA   Abe A., Kiyoi H., Ninomiya M., Yamazaki T., Murase T., Ozeki K.,
RA   Suzuki M., Hayakawa F., Katsumi A., Emi N., Naoe T.;
RT   "Establishment of a stroma-dependent human acute myelomonocytic
RT   leukemia cell line, NAMO-2, with FLT3 tandem duplication.";
RL   Int. J. Hematol. 84:328-336(2006).
//